HER2DX in early-stage HER2-positive breast cancer: a review of clinical utility.

Tolaney SM, Tung N, Wolff AC, DeMichele A, Cejalvo JM, Martínez-Sáez O, Pascual T, Waks AG, Nozawa K, Iwata H, Martín M, Ciruelos E, Harbeck N, Carey LA, Cortés J, Llombart A, Sharma P, Curigliano G

Open source

DOI: 10.1016/j.esmoop.2026.108345
Published: 2026 Sep
Container: ESMO open
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.esmoop.2026.108345,
  title = {HER2DX in early-stage HER2-positive breast cancer: a review of clinical utility.},
  author = {Tolaney SM and Tung N and Wolff AC and DeMichele A and Cejalvo JM and Martínez-Sáez O and Pascual T and Waks AG and Nozawa K and Iwata H and Martín M and Ciruelos E and Harbeck N and Carey LA and Cortés J and Llombart A and Sharma P and Curigliano G},
  year = {2026},
  journal = {ESMO open},
  doi = {10.1016/j.esmoop.2026.108345},
  url = {https://doi.org/10.1016/j.esmoop.2026.108345}
}

RIS

TY  - JOUR
TI  - HER2DX in early-stage HER2-positive breast cancer: a review of clinical utility.
AU  - Tolaney SM
AU  - Tung N
AU  - Wolff AC
AU  - DeMichele A
AU  - Cejalvo JM
AU  - Martínez-Sáez O
AU  - Pascual T
AU  - Waks AG
AU  - Nozawa K
AU  - Iwata H
AU  - Martín M
AU  - Ciruelos E
AU  - Harbeck N
AU  - Carey LA
AU  - Cortés J
AU  - Llombart A
AU  - Sharma P
AU  - Curigliano G
PY  - 2026
JO  - ESMO open
DO  - 10.1016/j.esmoop.2026.108345
UR  - https://doi.org/10.1016/j.esmoop.2026.108345
ER  -

APA

SM, T., N, T., AC, W., A, D., JM, C., O, M., T, P., AG, W., K, N., H, I., M, M., E, C., N, H., LA, C., J, C., A, L., P, S., & G, C. (2026). HER2DX in early-stage HER2-positive breast cancer: a review of clinical utility.. ESMO open. https://doi.org/10.1016/j.esmoop.2026.108345

Source records

pubmed · retrieved 2026-09-25T08:44:42.420Z